Risk Factors for Malignant Transformation of Mature Cystic Teratoma

Overview

Journal Obstet Gynecol Sci

Specialty Gynecology & Obstetrics

Date 2015 Dec 2

PMID 26623411

Citations 12

Authors

Chan-Hong Park

Min-Hyung Jung

Yong-Il Ji

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study was to investigate the preoperative characteristics of benign mature cystic teratoma (MCT) and struma ovarii and their risk factors associated malignancies, and determine the appropriate treatment options for these tumors.

Methods: This was a retrospective study on 248 patients who were pathologically diagnosed with ovarian MCT, struma ovarii, or malignant transformations of these tumors at Inje University Haeundae Paik Hospital from March 2010 to January 2015. Routinely evaluated results of adnexal masses before surgery were compared.

Results: A total of six patients (2.4%) were confirmed to have malignant tumors. Of the struma ovarii patients, two out of five patients (40%) were confirmed to have malignancy. The mean age at the diagnosis of patients with malignant transformation of teratomas was 43.0 years (range, 27 to 67 years), which was higher than that of patients with benign teratomas (36.5 years). The mean diameter of the tumor before surgery in the malignant tumor group was 11.4 cm and larger than 6.5 cm of benign group (P=0.003). The mean CA-125 level in the malignant tumor group was higher than that in the benign tumor group (P=0.01).

Conclusion: Risk factors for malignant transformation of MCT include elevated CA-125 levels, older age, large tumor masses, and postmenopausal status.

Citing Articles

Malignant Transformation in a Mature Cystic Teratoma of the Ovary: A 5-year Descriptive Study.

Billod J, Manangan-Wong R Acta Med Philipp. 2024; 58(15):55-60.

PMID: 39308880 PMC: 11413461. DOI: 10.47895/amp.vi0.8023.

A 10-year retrospective study of the risks and peculiarities in pediatric patients with (para)gonadal tumors and cysts.

Ataikiru U, Iacob E, Heredea E, Stanciulescu M, Galinescu M, Popoiu C Rom J Morphol Embryol. 2024; 65(2):225-241.

PMID: 39020537 PMC: 11384043. DOI: 10.47162/RJME.65.2.09.

Co-Existence of Endometriosis with Ovarian Dermoid Cysts: A Retrospective Cohort Study.

Kalaitzopoulos D, Samartzis N, Eberhard M, Grigoriadis G, Miliaras D, Papanikolaou A J Clin Med. 2023; 12(19).

PMID: 37834953 PMC: 10574005. DOI: 10.3390/jcm12196308.

Colorectal Adenocarcinoma Derived From Mature Cystic Teratomas: A Case Report With Review of the Literature.

Raja F, Kumar G, Hammad A, Ganesan S Cureus. 2023; 15(8):e44159.

PMID: 37753035 PMC: 10519183. DOI: 10.7759/cureus.44159.

Fat-containing adnexal masses on MRI: solid tissue volume and fat distribution as a guide for O-RADS Score assignment.

Cheng M, Andrieu P, Kim T, Gangai N, Sonoda Y, Hricak H Abdom Radiol (NY). 2022; 48(1):358-366.

PMID: 36173552 PMC: 11149608. DOI: 10.1007/s00261-022-03688-x.

References

Nagata H, Takahashi K, Yamane Y, Yoshino K, Shibukawa T, Kitao M . Abnormally high values of CA 125 and CA 19-9 in women with benign tumors. Gynecol Obstet Invest. 1989; 28(3):165-8. DOI: 10.1159/000293559. View

Kikkawa F, Ishikawa H, Tamakoshi K, Nawa A, Suganuma N, Tomoda Y . Squamous cell carcinoma arising from mature cystic teratoma of the ovary: a clinicopathologic analysis. Obstet Gynecol. 1997; 89(6):1017-22. DOI: 10.1016/s0029-7844(97)00117-8. View

Miyazaki K, Tokunaga T, Katabuchi H, Ohba T, Tashiro H, Okamura H . Clinical usefulness of serum squamous cell carcinoma antigen for early detection of squamous cell carcinoma arising in mature cystic teratoma of the ovary. Obstet Gynecol. 1991; 78(3 Pt 2):562-6. View

Dede M, Gungor S, Yenen M, Alanbay I, Duru N, Hasimi A . CA19-9 may have clinical significance in mature cystic teratomas of the ovary. Int J Gynecol Cancer. 2006; 16(1):189-93. DOI: 10.1111/j.1525-1438.2006.00284.x. View

Mori Y, Nishii H, Takabe K, Shinozaki H, Matsumoto N, Suzuki K . Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary. Gynecol Oncol. 2003; 90(2):338-41. DOI: 10.1016/s0090-8258(03)00259-2. View

Wee J, Li X, Chern B, Chua I . Struma ovarii: management and follow-up of a rare ovarian tumour. Singapore Med J. 2015; 56(1):35-9. PMC: 4325564. DOI: 10.11622/smedj.2015007. View

Kim S, Choi H, Byun J, Kim Y, Kim K, Rim S . Mucinous adenocarcinoma and strumal carcinoid tumor arising in one mature cystic teratoma of the ovary with synchronous cervical cancer. J Obstet Gynaecol Res. 2003; 29(1):28-32. DOI: 10.1046/j.1341-8076.2003.00073.x. View

Rim S, Kim S, Choi H . Malignant transformation of ovarian mature cystic teratoma. Int J Gynecol Cancer. 2006; 16(1):140-4. DOI: 10.1111/j.1525-1438.2006.00285.x. View

Stamp G, McConnell E . Malignancy arising in cystic ovarian teratomas. A report of 24 cases. Br J Obstet Gynaecol. 1983; 90(7):671-5. DOI: 10.1111/j.1471-0528.1983.tb09289.x. View

10.

Zorlu C, Kuscu E, Soysal M, Caglar T, Aydogdu T, Cobanoglu O . Malignant degeneration of mature cystic teratomas. Aust N Z J Obstet Gynaecol. 1996; 36(2):221-2. DOI: 10.1111/j.1479-828x.1996.tb03293.x. View

11.

KEMPERS R, DOCKERTY M, Hoffman D, Bartholomew L . Struma ovarii--ascitic, hyperthyroid, and asymptomatic syndromes. Ann Intern Med. 1970; 72(6):883-93. DOI: 10.7326/0003-4819-72-6-883. View

12.

Tseng C, Chou H, Huang K, Chang T, Liang C, Lai C . Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Gynecol Oncol. 1996; 63(3):364-70. DOI: 10.1006/gyno.1996.0337. View

13.

Ihalagama I, de S Hewavisenthi S, Wijesinghe P . Pregnancy following treated malignant struma ovarii. Ceylon Med J. 2004; 49(3):90-1. DOI: 10.4038/cmj.v49i3.3248. View

14.

Kelley R, Scully R . Cancer developing in dermoid cysts of the ovary. A report of 8 cases, including a carcinoid and a leiomyosarcoma. Cancer. 1961; 14:989-1000. DOI: 10.1002/1097-0142(196109/10)14:5<989::aid-cncr2820140512>3.0.co;2-u. View

15.

Gould S, Lopez R, Speers W . Malignant struma ovarii. A case report and literature review. J Reprod Med. 1983; 28(6):415-9. View

16.

Brammer 3rd H, Buck J, Hayes W, Sheth S, Tavassoli F . From the archives of the AFIP. Malignant germ cell tumors of the ovary: radiologic-pathologic correlation. Radiographics. 1990; 10(4):715-24. DOI: 10.1148/radiographics.10.4.2165627. View

17.

Singh P, Yordan E, Wilbanks G, Miller A, Wee A . Malignancy associated with benign cystic teratomas (dermoid cysts) of the ovary. Singapore Med J. 1988; 29(1):30-4. View

18.

Hirakawa T, Tsuneyoshi M, Enjoji M . Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Clinicopathologic and topographic analysis. Am J Surg Pathol. 1989; 13(5):397-405. DOI: 10.1097/00000478-198905000-00007. View

19.

PETERSON W . Malignant degeneration of benign cystic teratomas of the overy; a collective review of the literature. Obstet Gynecol Surv. 1957; 12(6):793-830. DOI: 10.1097/00006254-195712000-00001. View

20.

Caspi B, Lerner-Geva L, Dahan M, Chetrit A, Modan B, Hagay Z . A possible genetic factor in the pathogenesis of ovarian dermoid cysts. Gynecol Obstet Invest. 2003; 56(4):203-6. DOI: 10.1159/000074755. View